Brandywine Global Investment Management LLC Acquires 44,005 Shares of DaVita Inc. (NYSE:DVA)

Brandywine Global Investment Management LLC increased its position in shares of DaVita Inc. (NYSE:DVA - Free Report) by 68.5% during the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 108,272 shares of the company's stock after purchasing an additional 44,005 shares during the quarter. Brandywine Global Investment Management LLC owned approximately 0.13% of DaVita worth $16,192,000 as of its most recent SEC filing.

A number of other institutional investors have also added to or reduced their stakes in the company. California Public Employees Retirement System lifted its holdings in DaVita by 75.1% during the fourth quarter. California Public Employees Retirement System now owns 196,788 shares of the company's stock worth $29,430,000 after acquiring an additional 84,375 shares during the period. Allstate Corp bought a new stake in shares of DaVita during the 4th quarter worth $203,000. denkapparat Operations GmbH purchased a new position in shares of DaVita in the 4th quarter worth about $263,000. New Age Alpha Advisors LLC bought a new position in DaVita during the fourth quarter valued at about $1,782,000. Finally, Norges Bank bought a new stake in DaVita in the fourth quarter worth about $7,297,000. 90.12% of the stock is owned by institutional investors.

Analyst Ratings Changes

Several equities research analysts have recently issued reports on DVA shares. Cowen restated a "hold" rating on shares of DaVita in a research note on Tuesday, February 18th. Sanford C. Bernstein set a $184.00 price objective on DaVita in a report on Friday, February 21st. StockNews.com cut DaVita from a "buy" rating to a "hold" rating in a research report on Wednesday. Finally, Barclays lifted their price objective on DaVita from $164.00 to $169.00 and gave the stock an "equal weight" rating in a report on Tuesday, February 18th. One research analyst has rated the stock with a sell rating, five have assigned a hold rating and one has issued a buy rating to the company. According to MarketBeat, the stock presently has an average rating of "Hold" and a consensus price target of $166.33.

Remove Ads

DaVita Stock Performance

Shares of NYSE DVA traded down $2.13 during mid-day trading on Friday, hitting $151.60. The company had a trading volume of 202,770 shares, compared to its average volume of 807,802. The stock's 50-day moving average price is $156.16 and its 200-day moving average price is $157.39. The company has a market capitalization of $12.13 billion, a price-to-earnings ratio of 14.14, a P/E/G ratio of 1.07 and a beta of 1.04. The company has a current ratio of 1.26, a quick ratio of 1.21 and a debt-to-equity ratio of 23.18. DaVita Inc. has a 1 year low of $125.64 and a 1 year high of $179.60.

DaVita (NYSE:DVA - Get Free Report) last announced its quarterly earnings results on Thursday, February 13th. The company reported $2.24 earnings per share for the quarter, beating the consensus estimate of $2.14 by $0.10. DaVita had a return on equity of 115.48% and a net margin of 7.31%. On average, sell-side analysts forecast that DaVita Inc. will post 10.76 earnings per share for the current year.

DaVita Profile

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.